Generic Drug Classification Cases in Federal Circuit

Browse 1 generic drug classification cases decided by Federal Circuit. AI-powered summaries, holdings, and legal analysis.

1
Cases
1
Defendant Win

Generic Drug Classification Opinions from Federal Circuit (1)

Actavis Laboratories Fl, Inc. v. United States

Federal Circuit Clarifies Medicare Part D 'Substantially All' Drug Reimbursement Rule

Federal Circuit · 2025-03-21 · Defendant Win · Impact: 40/100

Actavis Laboratories Fl, Inc. v. United States, decided by Federal Circuit on March 21, 2025, resulted in a defendant win outcome. The case concerns the interpretation of the "substantially all" limit...

Frequently Asked Questions

Q: How many generic drug classification cases has Federal Circuit decided?

CaseLawBrief currently tracks 1 generic drug classification cases from Federal Circuit. This number is updated as new opinions are published.

Q: What types of outcomes occur in generic drug classification cases at Federal Circuit?

Outcome breakdown: Defendant Win: 1.

Q: Where can I find plain English summaries of generic drug classification rulings from Federal Circuit?

Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.

Explore More

All Federal Circuit Cases All Generic Drug Classification Cases All Courts All Topics Search